trending Market Intelligence /marketintelligence/en/news-insights/trending/JLv21CJU8Gf2gwtYZo0x4g2 content esgSubNav
In This List

PPF Group acquires 19.2% stake in Autolus Therapeutics

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends

Blog

Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook

Blog

Banking Essentials Newsletter 2021: December Edition


PPF Group acquires 19.2% stake in Autolus Therapeutics

PPF Group NV acquired a 19.2% stake in London-based Autolus Therapeutics PLC.

Netherlands-based PPF Group is a privately held investment fund with investments channeled into various industries including banking and financial services, telecommunications, real estate, mechanical engineering, biotechnology and insurance.

Autolus Therapeutics is a biopharmaceutical company developing T cell therapies for treating cancer. The company's lead program, dubbed AUTO1, is expected to enter a phase 2 study for treating a certain type of blood cancer later this year.